10x Genomics (NYSE:TXG) major shareholder Foresite Capital Fund I, L.P. bought 187,500 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average cost of $39.00 per share, for a total transaction of $7,312,500.00. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
About 10x Genomics
10x Genomics, Inc, a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems.
Recommended Story: What economic reports are most valuable to investors?
Receive News & Ratings for 10x Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 10x Genomics and related companies with MarketBeat.com's FREE daily email newsletter.